Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma
Citations
4,840 citations
1,298 citations
968 citations
541 citations
Cites methods from "Increasing use of gonadotropin-rele..."
...temporary androgen suppression treatment (AST) as an adjuvant management of prostate cancer.(1)...
[...]
532 citations
References
39,961 citations
"Increasing use of gonadotropin-rele..." refers methods in this paper
...Comorbidity was assessed by using Klabunde’s adaptation of the Charlson comorbidity index.(27,28) This analysis required Medicare claims in the 12 months before the diagnosis of prostate carcinoma and was therefore limited to subjects 66 years....
[...]
16,806 citations
"Increasing use of gonadotropin-rele..." refers methods in this paper
...The SEER staging used in the current study was based on earlier versions of the AJCC system, which included Stages 0 –IV.(24,25) For the purposes of the current study, 1616 CANCER April 15, 2005 / Volume 103 / Number 8...
[...]
...The SEER staging used in the current study was based on earlier versions of the AJCC system, which included Stages 0 –IV.24,25 For the purposes of the current study, the stages were reclassified to reflect most closely the current AJCC staging system.26 Briefly, Stage 0 was reclassified as Stage I, Stages I and II were reclassified as Stage II, and Stages III and IV were unchanged....
[...]
3,534 citations
3,277 citations